SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-117931
Filing Date
2016-05-05
Accepted
2016-05-05 18:32:24
Documents
3
Period of Report
2016-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7274
2 POA DOCUMENT poa.txt EX-24.3_652098 3996
3 EX-24.2 DOCUMENT attachment1.htm EX-24.2 4071
  Complete submission text file 0001209191-16-117931.txt   17398
Mailing Address 2929 7TH STREET, STE 120 BERKELEY CA 94710
Business Address 2929 7TH STREET, STE 120 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Reporting) CIK: 0001619856 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161625417

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2929 7TH ST., SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH ST., SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Therapeutics Holdco, LLC (Reporting) CIK: 0001671465 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37766 | Film No.: 161625418